AI Article Synopsis
- The study aimed to evaluate the characteristics and outcomes of left-side endocarditis caused by gram-negative bacteria, revealing it as a rare condition impacting significantly ill patients.
- Among 961 endocarditis cases studied, only 24 (2.5%) were linked to gram-negative bacteria, with Escherichia coli and Pseudomonas aeruginosa being the most common pathogens, often affecting native valves in patients with pre-existing health issues.
- Complications such as renal failure, central nervous system involvement, and high mortality rates (41%) were noted, and while aminoglycosides were commonly used, they did not improve patient outcomes.
Article Abstract
Introduction: The aim of this study is to describe the epidemiological, clinical characteristics, and outcome of patients with left-side endocarditis caused by gram-negative bacteria.
Method: Prospective multicenter study of left-sided infective endocarditis reported in the Andalusian Cohort for the Study of Cardiovascular Infections between 1984 and 2008.
Results: Among the 961 endocarditis, 24 (2.5%) were caused by gram-negative bacilli. The most common pathogens were Escherichia coli, Pseudomonas aeruginosa and Salmonella enterica. Native valves (85.7%) were mainly affected, most of them with previous valve damage (57%). Comorbidity was greater (90% vs 39%; P=.05) than in endocarditis due to other microorganism, the most frequent being, diabetes, hepatic cirrhosis and neoplasm. A previous manipulation was found in 47.6% of the cases, and 37% were considered hospital-acquired. Renal failure (41%), central nervous system involvement (33%) and ventricular dysfunction (45%) were the most frequent complications. Five cases (21%) required cardiac surgery, mostly due to ventricular dysfunction. More than 50% of cases were treated with aminoglycosides, but this did not lead to a better outcome or prognosis. Mortality (10 patients) was higher than that reported with other microorganisms (41% vs 35%; P=.05).
Conclusions: Left-sided endocarditis due to gram-negative bacilli is a rare disease, which affects patients with major morbidities and often with a previous history of hospital manipulations. Cardiac, neurological and renal complications are frequent and associated with a high mortality. The association of aminoglycosides in the antimicrobial treatment did not involve a better outcome or prognosis.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.eimc.2010.12.007 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
A rare case of Stenotrophomonas maltophilia endogenous endophthalmitis in pediatric age group.
J Ophthalmic Inflamm Infect
December 2024
Laboratory Services, Dr. Shroff's Charity Eye Hospital, New Delhi, India.
Background: We report a unique case of Stenotrophomonas maltophilia-related pediatric endogenous endophthalmitis.
Case Presentation: A 10-year-old male presented with redness and loss of vision in his right eye for two weeks. Clinical examination and ultrasound features were suggestive of endophthalmitis, most likely endogenous due to the absence of a history of trauma or intraocular intervention.
Discovery and Characterization of an Atypical Crustin Antimicrobial Peptide from .
Mar Drugs
November 2024
Guangxi Key Laboratory of Beibu Gulf Marine Biodiversity Conservation, Beibu Gulf University, Qinzhou 535011, China.
Crustins are a family of antimicrobial peptides (AMPs) that play a pivotal role in the innate immune system of crustaceans. The discovery of novel AMPs from natural sources is crucial for expanding our current database of these peptides. Here, we identified and characterized a novel member of the crustin family, named Crus-SWD1, derived from .
View Article and Find Full Text PDFUpdates on the Activity, Efficacy and Emerging Mechanisms of Resistance to Cefiderocol.
Curr Issues Mol Biol
December 2024
Department of Diagnostics and Public Health, Microbiology Section, Verona University, 37134 Verona, Italy.
In recent years, novel antimicrobials have been developed to counter the emergence of antimicrobial resistance and provide effective therapeutic options against multidrug-resistant (MDR) Gram-negative bacilli (GNB). Cefiderocol, a siderophore cephalosporin, represents a novel valuable antimicrobial drug for the treatment of infections caused by MDR-GNB. The mechanism of cefiderocol to penetrate through the outer membrane of bacterial cells, termed "", makes this antimicrobial drug unique and immune to the various resistance strategies adopted by GNB.
View Article and Find Full Text PDFAssociation of infection with colorectal cancer in Kazakhstani patients.
Front Oncol
December 2024
Department of Surgery, Nazarbayev University School of Medicine, Astana, Kazakhstan.
Objectives: is a gram-negative anaerobic bacillus associated with colorectal cancer (CRC). We aimed to determine the abundance of . and other CRC-associated bacteria using quantitative real-time polymerase chain reaction (qPCR) analysis to detect the possible correlations between tumor and normal tissues and the relationships between patients' clinical characteristics, diet, and CRC-associated bacteria.
View Article and Find Full Text PDFNovel coumarin linked pyrazoles, thiazoles, and thiadiazoles: synthetic strategies and in vitro antimicrobial investigation.
Future Med Chem
December 2024
Chemistry Department, Faculty of science(Girls), Al-Azhar University, Nasr City, Cairo, Egypt.
Aim: Emerging resistance among pathogens necessitates the development of novel antimicrobial agents. As a result, we aimed to synthesize new coumarins and study their antimicrobial activity with the hope of obtaining effective drugs.
Method: A series of coumarins were synthesized, characterized, and assessed for antimicrobial activity using broth microdilution and agar diffusion methods against Gram-positive (), Gram-negative () bacteria, and fungi ().
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!